ʻIke kumu
| inoa mea kūʻai | Heluhelu | ʻAno | Mea hoʻokipa/kumu | Hoʻohana | Nā noi | Epitope | COA |
| Kākoʻo Paʻa | BMGBL01 | Monoclonal | ʻiole | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
| Kākoʻo Paʻa | BMGBL02 | Monoclonal | ʻiole | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
| Kākoʻo Paʻa | BMGBL03 | ʻiole | ʻiole | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
| Kākoʻo Paʻa | BMGBLP1 | Polyclonal | ʻiole | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
| Kākoʻo Paʻa | BMGBLP2 | Polyclona | Lapi | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
| Kākoʻo Paʻa | BMGBLP3 | Polyclonal | Kao | Laʻana Pad Laʻau | LF, IFA, IB, WB | / | Hoʻoiho |
ʻO ka blocker kahi mea olaola i hoʻohui ʻia i kahi immunoassay e hoʻopaʻa i nā antibodies heterophile, e pale pono i ka ligation antibody non-analyte-mediated.
ʻO ka blocker kahi mea olaola i hoʻohui ʻia i kahi immunoassay e hoʻopaʻa i nā antibodies heterophile, e pale pono i ka ligation antibody non-analyte-mediated.Hoʻohana nui ʻia no ka enzyme-linked, immunofluorescence a me chemiluminescence.Hiki i nā blockers ke pale i ka hoʻopili i ka wā o ka hoʻāʻo, a ua māhele ʻia i nā blockers passive a me nā blockers ikaika.
